NCT01149421 A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01148498 A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's Status COMPLETED Phase PHASE2
NCT01147627 Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients Status COMPLETED Phase NA
NCT01144377 A Study of LY2541546 in Women With Low Bone Mineral Density Status COMPLETED Phase PHASE2
NCT01140893 Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes Status UNKNOWN Phase PHASE2/PHASE3
NCT01140347 A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib Status COMPLETED Phase PHASE3
NCT01139762 A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms Status COMPLETED Phase PHASE3
NCT01137006 An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant Melanoma Status COMPLETED Phase PHASE1
NCT01136746 Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin Status TERMINATED Phase PHASE3
NCT01134107 Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use Status COMPLETED Phase PHASE3
NCT01133405 A Safety Study of LY2886721 Single Doses in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01131676 BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME). Status COMPLETED Phase PHASE3
NCT01131104 A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors Status COMPLETED Phase N/A
NCT01127646 A Study in Attention Deficit Hyperactivity Disorder in Children and Adolescents Status TERMINATED Phase PHASE4